References and Notes
1a
Zhao BW.
Lu XY.
Org. Lett.
2006,
8:
5987
1b
Zhou CX.
Larock RC.
J. Am. Chem. Soc.
2004,
126:
2302
1c
Zhao BW.
Lu XY.
Tetrahedron Lett.
2006,
47:
6765
1d
Zhou CX.
Larock RC.
J. Org. Chem.
2006,
71:
3551
2
Ueura K.
Miyamura S.
Satoh T.
Miura M.
J. Organomet. Chem.
2006,
691:
2821
3a
Tsuji J.
Transition Metal Reagents and Catalysts
Wiley;
Chichester:
2004.
3b
Diederich F.
Stand PJ.
Metal-Catalyzed Cross-Coupling Reactions
Wiley-VCH;
Weinheim:
1998.
3c
Meijere A.
Diederich F.
Metal-Catalyzed Cross-Coupling Reaction
2nd ed.:
John Wiley and Sons;
Weinheim / Germany:
2004.
3d
Fagnou K.
Lautens M.
Chem. Rev.
2003,
103:
169
4a
Bedford RB.
Cazin CSJ.
Holder D.
Coord. Chem. Rev.
2004,
248:
2283
4b
Dupont J.
Consorti CS.
Spencer J.
Chem. Rev.
2005,
105:
2527
4c
Bedford RB.
Chem. Commun.
2003,
1787
4d
Beletskaya JP.
Cheprakov AV.
J. Organomet. Chem.
2004,
689:
4055
5
Li CJ.
Chem. Rev.
2005,
105:
3095
6
Anastas PT.
Williamson T.
Green Chemistry: Frontiers in Benign Chemical Syntheses and Processes
Oxford University Press;
Oxford:
1998.
7a
Ueura K.
Satoh T.
Miura M.
Org. Lett.
2005,
7:
2229
7b
Miyamura S.
Satoh T.
Miura M.
J. Org. Chem.
2007,
72:
2255
8
General Procedure
In a bottle was placed NH4Cl, which was then dried at 60 °C in vacuo for 6 h prior to use. A reaction vessel was charged with 0.5 mmol of benzonitrile, 1.5 mmol of PhB(OH)2, 3.0 mmol of NH4Cl, 0.5 mmol of sodium dodecyl sulfonate (SDS), Pd catalyst 2 in 2.0 mL of H2O incubated in a oil bath at 100 °C for 24 h. After cooling, the reaction mixture was diluted with 10 mL brine. The aqueous layer was extracted with CH2Cl2 and dried over Na2SO4. After evaporation of the solvent the residue was subjected to TLC (PE-CH2Cl2). The prepared compounds were identified by 1H NMR, 13C NMR, and MS. The new compound 3j was also identified by HRMS (ESI).
Selected Spectroscopic Data:
Catalyst 2: mp: 228-230 °C (dec.). 1H NMR (400 MHz, MeOD): δ = 2.12 (s, 3 H), 2.45 (s, 3 H), 4.36 (s, 5 H), 4.65 (t, J = 2.4 Hz, 1 H), 4.81 (d, J = 2.4 Hz, 1 H), 4.95 (d, J = 2.0 Hz, 1 H), 6.33 (d, J = 4.8 Hz, 1 H), 7.13 (t, J = 6.0 Hz, 3 H), 7.38 (d, J = 6.8 Hz, 2 H), 7.79 (t, J = 6.0 Hz, 1 H), 8.02 (t, J = 7.6 Hz, 1 H), 8.27 (t, J = 7.6 Hz, 1 H), 8.35 (d, J = 7.6 Hz, 1 H), 8.43 (d, J = 7.6 Hz, 1 H), 9.20 (d, J = 4.8 Hz, 1 H). 13C NMR (100 MHz, MeOD): δ = 17.3, 21.1, 70.6, 70.8, 72.2, 75.0, 92.1, 98.8, 124.2, 125.3, 127.3, 128.6, 131.8, 139.4, 141.4, 141.8, 145.5, 149.8, 154.1, 155.5, 157.8, 189.4. HRMS (ESI+): m/z calcd for C29H26N3FeClPd [M - Cl]+: 578.0511; found: 578.0518. IR (KBr): ν = 3018, 1633, 1600, 1473, 1438, 1368, 1227, 1153, 1106, 1073, 1027, 810, 776, 494 cm-1.
Compound 3a: 1H NMR (400 MHz, CDCl3): δ = 2.40 (s, 3 H), 4.26 (s, 2 H), 7.23-7.32 (m, 7 H), 7.91 (d, J = 7.4 Hz, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 21.7, 45.4, 126.8, 128.6, 128.8, 129.3, 129.4, 134.1, 134.8, 144.0, 197.3 ppm. MS (ESI+): m/z = 211.1 [M + H]+, 233.1 [M + Na]+, 249.0 [M + K]+.
Compound 3c: 1H NMR (400 MHz, CDCl3): δ = 3.86 (s, 3 H), 4.23 (s, 2 H), 6.91-6.94 (m, 2 H), 7.24-7.33 (m, 5 H), 7.98-8.00 (m, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 45.3, 55.5, 113.8, 126.8, 128.6, 129.4, 129.7, 131.0, 135.0, 163.5, 196.2 ppm. MS (ESI+): m/z = 227.3 [M + H]+, 249.2 [M + Na]+, 265.2 [M + K]+.
Compound 3e: 1H NMR (400 MHz, CDCl3): δ = 4.27 (s, 2 H), 7.25-7.28 (m, 5 H), 7.32-7.36 (m, 2 H), 8.05-8.07 (m, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 45.6, 120.3 (q, J = 257.4 Hz), 120.4, 127.1, 128.8, 129.4, 130.6, 134.1, 134.8, 152.7, 196.0 ppm. MS (ESI+): m/z = 281.0 [M + H]+, 303.1 [M + Na]+, 319.0 [M + K]+.
Compound 3f: 1H NMR (400 MHz, CDCl3): δ = 7.47 (t, J = 7.6 Hz, 4 H), 7.57 (t, J = 7.4 Hz, 2 H), 7.79-7.81 (m, 4 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 128.2, 130.0, 132.3, 137.5, 196.7 ppm. MS (ESI+): m/z = 183.1 [M + H]+, 205.1 [M + Na]+, 221.0 [M + K]+.
Compound 3j: 1H NMR (400 MHz, CDCl3): δ = 7.52-7.56 (m, 2 H), 7.66-7.70 (m, 1 H), 7.80-7.83 (m, 2 H), 8.00-8.04 (m, 2 H), 8.17-8.19 (m, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 119.7 (q, J = 324.1 Hz), 128.8, 130.2, 130.7, 130.9, 133.8, 134.2, 135.9, 144.8, 194.6 ppm. MS (ESI+): m/z = 337.4 [M + Na]+, 353.7 [M + K]+. HRMS (ESI+): m/z calcd for C14H9F3SO3 [M + H]+: 315.0303; found: 315.0300.
Compound 3k: 1H NMR (400 MHz, CDCl3): δ = 6.92-6.96 (m, 2 H), 7.46-7.49 (m, 2 H), 7.55-7.59 (m, 1 H), 7.75-7.80 (m, 4 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 115.4, 128.3, 129.7, 129.9, 132.2, 133.1, 138.0, 160.6, 196.7 ppm. MS (ESI+): m/z = 199.2 [M + H]+, 221.1 [M + Na]+, 237.1 [M + K]+.
Compound 3l: 1H NMR (400 MHz, CDCl3): δ = 5.28 (s, 2 H), 6.94-7.01 (m, 3 H), 7.26-7.31 (m, 2 H), 7.48-7.52 (m, 2 H), 7.60-7.64 (m, 1 H), 8.00-8.02 (m, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 70.8, 114.8, 121.7, 128.2, 128.8, 129.6, 133.9, 134.6, 158.0, 194.6 ppm. MS (ESI+): m/z = 213.1 [M + H]+, 235.0 [M + Na]+, 251.0 [M + K]+.
Compound 3m: 1H NMR (400 MHz, CDCl3): δ = 7.53 (t, J = 7.7, 2 H), 6.64-7.68 (m, 1 H), 7.79-7.81 (m, 2 H), 7.93-7.96 (m, 2 H), 8.33-8.36 (m, 2 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 123.6, 128.7, 130.1, 130.7, 133.5, 136.3, 142.9, 149.9, 194.8 ppm. MS (ESI+): m/z = 228.4 [M + H]+, 250.3 [M + Na]+.